| Pazopanib - Wikipedia, the free encyclopedia Pazopanib (trade name Votrient) is a potent and selective multi-targeted receptor tyrosine kinase inhibitor of VEGFR -1, VEGFR-2, VEGFR-3, PDGFR -a/β, and c-kit that ... Read More |
| Pazopanib (Brand name Votrient) Pazopanib hydrochloride has been approved by the US FDA for the treatment of kidney cancer. The drug is marketed in the US under the trade name ... Read More |
| FDA Approval for Pazopanib Hydrochloride - National Cancer Institute Information from the FDA about the approval of this drug and the clinical trials that led to the approval. Read More |
| Pazopanib: MedlinePlus Drug Information - National Library of ... Pazopanib may cause severe or life-threatening liver damage. Tell your doctor if you have or have ever had liver disease. If you experience any of the ... Read More |
| Pazopanib - PubMed Health - National Center for Biotechnology ... Pazopanib is used to treat advanced renal cell carcinoma (RCC, a type of cancer that begins in the cells of the kidneys) in adults. Pazopanib is in a class ... Read More |
| Complete Pazopanib information from Drugs.com Pazopanib professional patient advice. Specific and up to date information about Pazopanib. Read More |
| pazopanib - MSN Health - Medications Pazopanib is a cancer medication that interferes with the growth of cancer cells and slows their spread in the body. Pazopanib is used to treat advanc Read More |
| pazopanib medical facts from Drugs.com Physician reviewed pazopanib patient information - includes pazopanib description, dosage and directions. Read More |
| Votrient (Pazopanib Tablets) Drug Information: Description, User ... Learn about the prescription medication Votrient (Pazopanib Tablets), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Read More |
| Pazopanib - American Cancer Society :: Information and Resources ... Pazopanib (pah-zoe-puh-nib) Trade/Other Name(s): Votrient. Why would this drug be used? Pazopanib is used to treat kidney cancer and soft tissue sarcoma. Read More |
